Date Range
Date Range
Date Range
Welcome to Crescent Capital Partners. Crescent has had a strong track record in delivering superior returns to investors through successful exits.
A stable model for future growth. Crown Castle Completes Acquisition of Sunesys. Crown Castle Declares Quarterly Common Stock Dividend. Crown Castle Reports Second Quarter 2015 Results and Raises Outlook for 2015. Crown Castle Announces Second Quarter 2015 Earnings Release and Conference Call Schedule.
I have read this disclaimer. ,Box 3005, Columbus, IN 47202-3005 U.
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyalumes financial performance into perspective. Delayed at least 20 minutes. Cyalume Technologies Holdings, Inc. to Be Acquired by an Affiliate of Arsenal Capital Partners.
CYC116 Aurora Kinase and VEGFR2 Inhibitor. Drug Discovery and Development Approach. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyclacel Pharmaceuticals, Inc. Fourth Quarter and Full Year 2017 Financial Results.